US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.87

-0.2800-1.11%

Post-market: 24.870.00000.00%19:30 EDT

Volume:23.02K

Turnover:576.09K

Market Cap:57.70M

PE:- -

High:25.58

Open:25.53

Low:24.67

Close:25.15

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.72

T/O Rate:0.99%

Dividend:1.71

Dividend Rate:6.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says

MT Newswires Live

Compass Pathways to Report Q2, First-half Results, Host Conference Call

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

THOMSON REUTERS

Microba Raises $5.4m Through Placement and SPP Ahead of FY26 Results

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS

Lakes Blue Energy Highlights Exploration Risks in Capital Raising Brief

Lakes Blue Energy launches $8.7m capital raising and reshapes board

Acrow shareholders back capital raisings at extraordinary meeting

Vita Resources Ends Oakley Capital Mandate as It Resets Funding Strategy

Wall Street Analysts Are Bullish on Top Healthcare Picks

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary

Alkermes Releases Transcript of Q2 2026 Earnings Call

Alkermes sinks 5% to $50.05 following Q2 report

Relmada Therapeutics Names Bipin Dalmia Chief Business Officer

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

THOMSON REUTERS

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/PSIL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.87,"timestamp":1789761600000,"preClose":25.15,"halted":0,"volume":23017,"hourTrading":{"tag":"盘后","latestPrice":24.87,"preClose":24.87,"latestTime":"19:30 EDT","volume":13,"amount":323.31,"timestamp":1789774204499,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011133200795228533,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Market Closed","change":-0.28,"latestTime":"09-18 16:00:00 EDT","open":25.53,"high":25.58,"low":24.67,"amount":576091.019912,"amplitude":0.036183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":25.15,"sharesOutstanding":1184976,"nav":24.676,"aum":57248825.63,"dividendRate":0.068565,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.86,"preClose":25.15,"latestTime":"09:17 EDT","volume":28,"amount":719.9700200000001,"timestamp":1789737431335,"change":0.71,"changeRate":0.028231,"amplitude":0.020278},"postHourTrading":{"tag":"盘后","latestPrice":24.87,"preClose":24.87,"latestTime":"19:30 EDT","volume":13,"amount":323.31,"timestamp":1789774204499,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7196050720575493,"impliedVol":0.3416,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7196050720575493,"shares":2319976,"dividePrice":1.7052,"high":25.58,"amplitude":0.036183,"preClose":25.15,"low":24.67,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.87,"eps":0,"divideRate":0.068565,"volume":23017,"delay":0,"ttmEps":0,"open":25.53,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.7682,"twentyDayClose":25.95,"sixtyDayClose":21.7221},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655926538","title":"Alkermes' Core Business Backed Q2 Beat, Orexin Pipeline to Serve as Catalyst, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2655926538","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655926538?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:53","pubTimestamp":1785340439,"startTime":"0","endTime":"0","summary":"Alkermes'  base business supported the company's Q2 beat, while its orexin pipeline serves as a potential catalyst for future revenue growth, RBC Capital Markets said in a Tuesday note.The company reported a breakeven in Q2, compared with earnings of $0.52 per share a year earlier, and revenue of $496 million, up from $390.7 million. For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion.Alkermes' core business drove the quarter's revenue beat, with recent highlights like less generic threat for Vivitrol and expanded access for Lybalvi, RBC said. The quarter also said one-time benefits from patient mix favorability, Lumryz inventory and Consta manufacturing, the brokerage added.Looking forward, investor focus is shifting to the company's orexin pipeline expansion into other indications, which could help pave the way for Alkermes's revenue to exceed $5 billion, RBC noted.RBC has an outperform rating and $56 price target on Alkermes.Price: 48.40, Chang","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBRN","BK4139","FBT","MEDX","ALKS","PSIL","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886917","title":"Compass Pathways to Report Q2, First-half Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886917","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886917?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:31","pubTimestamp":1785321066,"startTime":"0","endTime":"0","summary":"Compass Pathways to report Q2, first-half results, host conference callCompass Pathways will report Q2 and first-half results for the period ended June 30, 2026 on Aug. 5, 2026.Management will host a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4ncJ40:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655910869","title":"Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655910869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655910869?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:30","pubTimestamp":1785321000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1JWLJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655857841","title":"Microba Raises $5.4m Through Placement and SPP Ahead of FY26 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2655857841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655857841?lang=en_us&edition=fundamental","pubTime":"2026-07-29 15:36","pubTimestamp":1785310579,"startTime":"0","endTime":"0","summary":"Microba Life Sciences Limited ( ($AU:MAP) ) has issued an update. Microba Life Sciences has completed a capital raising via a two-tranche placement...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/microba-raises-5-4m-through-placement-and-spp-ahead-of-fy26-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/microba-raises-5-4m-through-placement-and-spp-ahead-of-fy26-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385647","title":"Alkermes Plc : Jefferies Raises Target Price to $72 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385647?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:45","pubTimestamp":1785303957,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","ALKS","IBRN","MEDX","BK4139","FBT","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655855711","title":"Alkermes Plc : TD Cowen Raises Target Price to $58 from $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2655855711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655855711?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:22","pubTimestamp":1785302541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","MEDX","PSIL","PSCH","ALKS","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655853939","title":"Alkermes Plc : Baird Raises Target Price to $58 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2655853939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655853939?lang=en_us&edition=fundamental","pubTime":"2026-07-29 12:22","pubTimestamp":1785298959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","BK4139","FBT","PSCH","PSIL","ALKS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655581578","title":"Lakes Blue Energy Highlights Exploration Risks in Capital Raising Brief","url":"https://stock-news.laohu8.com/highlight/detail?id=2655581578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655581578?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:37","pubTimestamp":1785296243,"startTime":"0","endTime":"0","summary":"Lakes Blue Energy NL ( ($AU:LKO) ) has issued an announcement. Lakes Blue Energy NL has released a capital raising presentation outlining its curre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-highlights-exploration-risks-in-capital-raising-brief?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-highlights-exploration-risks-in-capital-raising-brief?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655858154","title":"Lakes Blue Energy launches $8.7m capital raising and reshapes board","url":"https://stock-news.laohu8.com/highlight/detail?id=2655858154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655858154?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:37","pubTimestamp":1785296235,"startTime":"0","endTime":"0","summary":"The latest update is out from Lakes Blue Energy NL ( ($AU:LKO) ). Lakes Blue Energy NL has completed a $4.0 million placement and launched a partia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-launches-8-7m-capital-raising-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-launches-8-7m-capital-raising-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655485884","title":"Acrow shareholders back capital raisings at extraordinary meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655485884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655485884?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:52","pubTimestamp":1785293562,"startTime":"0","endTime":"0","summary":"Acrow Formwork and Construction Services Limited ( ($AU:ACF) ) just unveiled an announcement. Acrow Limited has reported that shareholders at its 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrow-shareholders-back-capital-raisings-at-extraordinary-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrow-shareholders-back-capital-raisings-at-extraordinary-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655836622","title":"Vita Resources Ends Oakley Capital Mandate as It Resets Funding Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836622?lang=en_us&edition=fundamental","pubTime":"2026-07-29 06:28","pubTimestamp":1785277692,"startTime":"0","endTime":"0","summary":"An announcement from Bastion Minerals Ltd ( ($AU:VTA) ) is now available. Vita Resources NL has terminated its capital raising mandate with Oakley ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vita-resources-ends-oakley-capital-mandate-as-it-resets-funding-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vita-resources-ends-oakley-capital-mandate-as-it-resets-funding-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884804","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655884804?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:00","pubTimestamp":1785261615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Incyte (INCY) with bullish senti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","ALKS","IBRN","MEDX","PSCH","INCY","IDNA","PSIL","BK4585","BK4550","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655264886","title":"Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2655264886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655264886?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:10","pubTimestamp":1785255000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","PSCH","FBT","MEDX","PSIL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654424888","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654424888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654424888?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:20","pubTimestamp":1785248424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS) and Universal Health (UHS). Alkermes (ALKS) Needh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","XLV","LU0029874061.USD","BK4588","LU0128526141.USD","XBI","PSIL","BK4137","UHS","LABU","IBRN","BK4581","BK4185","ALKS","FBT","BK4585","BK4139","HCSG","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654700086","title":"Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2654700086","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654700086?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:32","pubTimestamp":1785245569,"startTime":"0","endTime":"0","summary":"Alkermes Plc reports results for the quarter ended June 30 - Earnings SummaryAlkermes PlcALKS.OQreported quarterly breakeven results per share for the quarter ended June 30, lower than the same quarte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL8N43U1WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","FBT","IBRN","PSIL","ALKS","BK4139","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071550","title":"Alkermes Releases Transcript of Q2 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071550?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:17","pubTimestamp":1785244649,"startTime":"0","endTime":"0","summary":"Alkermes releases transcript of Q2 2026 earnings callAlkermes discussed Q2 2026 results on an earnings call attended by CEO Richard Pops, CFO Joshua Reed, CCO Todd Nichols, COO and incoming CEO Blair ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL35dZmZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","FBT","PSCH","IBRN","ALKS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007833","title":"Alkermes sinks 5% to $50.05 following Q2 report","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007833","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007833?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:50","pubTimestamp":1785243027,"startTime":"0","endTime":"0","summary":"08:45 EDT Alkermes (ALKS) sinks 5% to $50.05 following Q2 report Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","FBT","MEDX","BK4139","IBRN","PSIL","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047370","title":"Relmada Therapeutics Names Bipin Dalmia Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047370","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047370?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:30","pubTimestamp":1785241852,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics names Bipin Dalmia chief business officerRelmada named Bipin Dalmia as chief business officer, leading corporate strategy, commercial planning, business development; reporting to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLFbB7t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014013.SGD","RLMD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","BCDF","SG9999014021.USD","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","BK4007","BK4588","PSIL","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004205","title":"Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004205?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:30","pubTimestamp":1785241801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA1ZDKJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100907","title":"Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100907","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100907?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:42","pubTimestamp":1785238953,"startTime":"0","endTime":"0","summary":"Alkermes  reported break-even earnings for Q2 Tuesday, compared with earnings of $0.52 per share a year earlier.Analysts polled by FactSet expected a loss of $0.03.Total revenue for the quarter ended June 30 was $496 million, up from $390.7 million a year earlier.Analysts surveyed by FactSet expected $457.4 million.For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion. Analysts polled by FactSet expected $1.81 billion.Shares of the company were up less than 1% in recent Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PSIL","BK4139","PSCH","MEDX","FBT","ALKS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}